RRC:NYSERange Resources Corporation Analysis
Data as of 2026-09-07 - not real-time
$42.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At $42.00, Range Resources Corporation shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 7.8%. With RSI at 61.5 the momentum picture is approaching overbought, alongside a bullish MACD signal. Price has been bracketed by support at $38.71 and resistance at $43.06.
Multiples put this in undervalued territory: 11.6 times earnings against the sector's 17.8. Sell-side targets cluster 8.7% above the current quote. Revenue is growing at 8.6% on a 26.3% profit margin. The 0.95% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 29.4%, a beta of -0.14 and a maximum drawdown of 25.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 8/10.
Multiples put this in undervalued territory: 11.6 times earnings against the sector's 17.8. Sell-side targets cluster 8.7% above the current quote. Revenue is growing at 8.6% on a 26.3% profit margin. The 0.95% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 29.4%, a beta of -0.14 and a maximum drawdown of 25.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 8/10.
Top Market Events
Range Resources has delivered a very strong 166.Range Resources stock is backed by solid Q2 2026 earnings growth and a higher 2026 dividend, as theIt has been about a month since the last earnings report for Range Resources RRC .
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Trading above the 200-day average of 39.26
- MACD momentum is positive
- 30-day price change of +7.8%
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 11.6 versus sector average of 17.8
- Trading above the 200-day average of 39.26
- Analyst targets imply +8.7% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- P/E of 11.6 versus sector average of 17.8
- Analyst targets imply +8.7% versus the current price
- Profit margin of 26.3% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin26.31%
P/E Ratio11.6
ROE19.48%
ROA10.47%
Debt/Equity21.59
P/B Ratio2.1
Op. Cash Flow$1.4B
Free Cash Flow$454.5M
Industry P/E17.8
Technical Analysis
TrendNeutral
RSI61.5
Support$38.71
Resistance$43.06
MA 20$41.00
MA 50$39.08
MA 200$39.26
MACDBullish
VolumeStable
Fear & Greed Index94.11
Valuation
Fair Value$31.06
Target Price$45.64
Upside/Downside8.66%
GradeUndervalued
TypeBlend
Dividend Yield0.95%
Risk Assessment
Beta-0.14
Volatility29.45%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.